Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
Cell Rep ; 36(6): 109511, 2021 08 10.
Artículo en Inglés | MEDLINE | ID: mdl-34380034

RESUMEN

Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder that often presents with psychiatric conditions, including autism spectrum disorder (ASD). ASD is characterized by restricted, repetitive, and inflexible behaviors, which may result from abnormal activity in striatal circuits that mediate motor learning and action selection. To test whether altered striatal activity contributes to aberrant motor behaviors in the context of TSC, we conditionally deleted Tsc1 from direct or indirect pathway striatal projection neurons (dSPNs or iSPNs, respectively). We find that dSPN-specific loss of Tsc1 impairs endocannabinoid-mediated long-term depression (eCB-LTD) at cortico-dSPN synapses and strongly enhances corticostriatal synaptic drive, which is not observed in iSPNs. dSPN-Tsc1 KO, but not iSPN-Tsc1 KO, mice show enhanced motor learning, a phenotype observed in several mouse models of ASD. These findings demonstrate that dSPNs are particularly sensitive to Tsc1 loss and suggest that enhanced corticostriatal activation may contribute to altered motor behaviors in TSC.


Asunto(s)
Cuerpo Estriado/metabolismo , Endocannabinoides/metabolismo , Aprendizaje , Depresión Sináptica a Largo Plazo , Actividad Motora/fisiología , Vías Nerviosas/fisiología , Neuronas/metabolismo , Proteína 1 del Complejo de la Esclerosis Tuberosa/metabolismo , Animales , Eliminación de Gen , Hipertrofia , Diana Mecanicista del Complejo 1 de la Rapamicina/metabolismo , Ratones Noqueados , Mutación/genética , Transducción de Señal , Sinapsis/metabolismo , Transmisión Sináptica , Proteína 1 del Complejo de la Esclerosis Tuberosa/genética , Regulación hacia Arriba
3.
BMC Cancer ; 21(1): 570, 2021 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-34006247

RESUMEN

BACKGROUND: Adjuvant endocrine therapies are known to induce undesirable adverse effects such as vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients. Drugs used in these therapies are often metabolised by cytochrome P450 (CYP) enzymes, in which their metabolising activities can be modified by single nucleotide polymorphisms (SNP) in CYP genes and CYP genotypes. This review aims to explore whether SNPs or genotypes of CYP are associated with the occurrence, frequency and severity of vasomotor, vaginal and musculoskeletal symptoms in breast cancer patients on adjuvant endocrine therapies. METHODS: A literature review was conducted using five electronic databases, resulting in the inclusion of 14 eligible studies, and their findings were presented narratively. Selected items from the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist were used for critical appraisal of the reporting quality of the included studies. RESULTS: Most of the included studies showed that SNPs or genotypes of CYP that modify its metabolising activity have no effect on the occurrence, frequency or severity of vasomotor symptoms, including hot flashes. One study showed no correlation of these genetic variations in CYP with musculoskeletal symptoms, and no data were available on the association between such genetic variations and vaginal symptoms. CONCLUSIONS: Overall, genetic variations in CYP have no effect on the experience of hot flashes among breast cancer patients. We recommend exploration of the link between the active metabolites of chemotherapeutic drugs and the molecules shown to affect the occurrence or severity of hot flashes, and the establishment of the relationship between such genetic variations and patients' experience of musculoskeletal and vaginal symptoms. Subgroup analyses based on patients' duration of adjuvant endocrine therapies in such studies are recommended.


Asunto(s)
Antineoplásicos Hormonales/efectos adversos , Artralgia/epidemiología , Neoplasias de la Mama/terapia , Sistema Enzimático del Citocromo P-450/genética , Sofocos/epidemiología , Vagina/patología , Antineoplásicos Hormonales/farmacocinética , Artralgia/inducido químicamente , Artralgia/diagnóstico , Artralgia/genética , Atrofia/inducido químicamente , Atrofia/diagnóstico , Atrofia/epidemiología , Atrofia/genética , Neoplasias de la Mama/genética , Quimioterapia Adyuvante/efectos adversos , Quimioterapia Adyuvante/métodos , Sistema Enzimático del Citocromo P-450/metabolismo , Antagonistas de Estrógenos/efectos adversos , Antagonistas de Estrógenos/farmacocinética , Estrógenos/metabolismo , Femenino , Predisposición Genética a la Enfermedad , Sofocos/inducido químicamente , Sofocos/diagnóstico , Sofocos/genética , Humanos , Mastectomía , Estudios Observacionales como Asunto , Polimorfismo de Nucleótido Simple , Índice de Severidad de la Enfermedad , Tamoxifeno/efectos adversos , Tamoxifeno/análogos & derivados , Tamoxifeno/farmacocinética , Vagina/efectos de los fármacos
4.
Dev Cell ; 51(6): 787-803.e5, 2019 12 16.
Artículo en Inglés | MEDLINE | ID: mdl-31735669

RESUMEN

The use of adult Drosophila melanogaster as a model for hematopoiesis or organismal immunity has been debated. Addressing this question, we identify an extensive reservoir of blood cells (hemocytes) at the respiratory epithelia (tracheal air sacs) of the thorax and head. Lineage tracing and functional analyses demonstrate that the majority of adult hemocytes are phagocytic macrophages (plasmatocytes) from the embryonic lineage that parallels vertebrate tissue macrophages. Surprisingly, we find no sign of adult hemocyte expansion. Instead, hemocytes play a role in relaying an innate immune response to the blood cell reservoir: through Imd signaling and the Jak/Stat pathway ligand Upd3, hemocytes act as sentinels of bacterial infection, inducing expression of the antimicrobial peptide Drosocin in respiratory epithelia and colocalizing fat body domains. Drosocin expression in turn promotes animal survival after infection. Our work identifies a multi-signal relay of organismal humoral immunity, establishing adult Drosophila as model for inter-organ immunity.


Asunto(s)
Células Sanguíneas/metabolismo , Hematopoyesis/fisiología , Macrófagos/metabolismo , Mucosa Respiratoria/metabolismo , Animales , Drosophila/metabolismo , Hemocitos/metabolismo , Inmunidad Celular/inmunología , Inmunidad Innata/inmunología , Quinasas Janus/metabolismo , Factores de Transcripción/metabolismo
5.
Nat Commun ; 10(1): 5426, 2019 11 28.
Artículo en Inglés | MEDLINE | ID: mdl-31780742

RESUMEN

Tuberous Sclerosis Complex (TSC) is a neurodevelopmental disorder caused by mutations in TSC1 or TSC2, which encode proteins that negatively regulate mTOR complex 1 (mTORC1). TSC is associated with significant cognitive, psychiatric, and behavioral problems, collectively termed TSC-Associated Neuropsychiatric Disorders (TAND), and the cell types responsible for these manifestations are largely unknown. Here we use cell type-specific Tsc1 deletion to test whether dopamine neurons, which modulate cognitive, motivational, and affective behaviors, are involved in TAND. We show that loss of Tsc1 and constitutive activation of mTORC1 in dopamine neurons causes somatodendritic hypertrophy, reduces intrinsic excitability, alters axon terminal structure, and impairs striatal dopamine release. These perturbations lead to a selective deficit in cognitive flexibility, preventable by genetic reduction of the mTOR-binding protein Raptor. Our results establish a critical role for Tsc1-mTORC1 signaling in setting the functional properties of dopamine neurons, and indicate that dopaminergic dysfunction may contribute to cognitive inflexibility in TSC.


Asunto(s)
Cognición/fisiología , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Neuronas Dopaminérgicas/metabolismo , Diana Mecanicista del Complejo 1 de la Rapamicina/metabolismo , Proteína 1 del Complejo de la Esclerosis Tuberosa/genética , Animales , Axones/patología , Conducta Animal , Cuerpo Celular/patología , Cuerpo Estriado/patología , Neuronas Dopaminérgicas/patología , Técnicas de Inactivación de Genes , Hipertrofia , Ratones , Motivación , Plasticidad Neuronal/genética , Transducción de Señal , Esclerosis Tuberosa/genética , Esclerosis Tuberosa/psicología , Proteína 1 del Complejo de la Esclerosis Tuberosa/metabolismo
6.
Nat Commun ; 8: 15990, 2017 07 27.
Artículo en Inglés | MEDLINE | ID: mdl-28748922

RESUMEN

An outstanding question in animal development, tissue homeostasis and disease is how cell populations adapt to sensory inputs. During Drosophila larval development, hematopoietic sites are in direct contact with sensory neuron clusters of the peripheral nervous system (PNS), and blood cells (hemocytes) require the PNS for their survival and recruitment to these microenvironments, known as Hematopoietic Pockets. Here we report that Activin-ß, a TGF-ß family ligand, is expressed by sensory neurons of the PNS and regulates the proliferation and adhesion of hemocytes. These hemocyte responses depend on PNS activity, as shown by agonist treatment and transient silencing of sensory neurons. Activin-ß has a key role in this regulation, which is apparent from reporter expression and mutant analyses. This mechanism of local sensory neurons controlling blood cell adaptation invites evolutionary parallels with vertebrate hematopoietic progenitors and the independent myeloid system of tissue macrophages, whose regulation by local microenvironments remain undefined.


Asunto(s)
Proteínas de Drosophila/metabolismo , Drosophila melanogaster/crecimiento & desarrollo , Hematopoyesis , Sistema Hematopoyético/metabolismo , Hemocitos/metabolismo , Subunidades beta de Inhibinas/metabolismo , Larva/crecimiento & desarrollo , Células Receptoras Sensoriales/metabolismo , Animales , Carbacol/farmacología , Supervivencia Celular , Microambiente Celular , Agonistas Colinérgicos/farmacología , Proteínas de Drosophila/efectos de los fármacos , Drosophila melanogaster/efectos de los fármacos , Drosophila melanogaster/metabolismo , Sistema Hematopoyético/efectos de los fármacos , Hemocitos/efectos de los fármacos , Larva/efectos de los fármacos , Larva/metabolismo , Sistema Nervioso Periférico/efectos de los fármacos , Sistema Nervioso Periférico/metabolismo , Células Receptoras Sensoriales/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...